share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  08/02 11:39
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value, have not been disclosed in the announcement. Investors are advised to monitor official filings for complete transaction details.
Pfizer Inc. (PFE) Chairman & CEO, Albert Bourla, has been reported to engage in a transaction involving the company's stock on July 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and total value, have not been disclosed in the announcement. Investors are advised to monitor official filings for complete transaction details.
據報道,輝瑞公司(PFE)主席兼CEO阿爾伯特·博爾拉於2024年7月31日涉嫌進行該公司股票交易。交易的具體細節,包括股份數量、股份性質、交易價格和總價值,在公告中沒有透露。投資者應監控官方文件以獲取完整的交易詳情。
據報道,輝瑞公司(PFE)主席兼CEO阿爾伯特·博爾拉於2024年7月31日涉嫌進行該公司股票交易。交易的具體細節,包括股份數量、股份性質、交易價格和總價值,在公告中沒有透露。投資者應監控官方文件以獲取完整的交易詳情。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息